The indirect comparative analysis is the first of its kind to assess the relative efficacy of approved covalent Bruton tyrosine kinase inhibitors (cBTKis) in the absence of head-to-head trials.

Connect with Murtaza Hussain on LinkedIn for more insights and discussions on the latest trends and challenges in the world of fintech. In this article, I would like to dive into an intriguing topic: ...